The Philadelphia Flyers announced on Friday that forward Oskar Lindblom has been diagnosed with Ewing’s sarcoma, a form of bone cancer.
He will be sidelined for the remainder of the season as he goes through treatment.
Flyers general manager Chuck Fletcher released the following statement:
“Philadelphia Flyers forward Oskar Lindblom has been diagnosed with Ewing’s sarcoma by leading specialists at the University of Pennsylvania. He will undergo further testing and evaluation next week and begin treatment immediately thereafter. He is not expected to return to play for the remainder of the season. The Flyers will do everything possible to support Oskar and assist him in securing the best care available. Out of respect for Oskar and his family, the team will have no further comment at this time and asks that Oskar be afforded a period of privacy so that he may focus his efforts on his treatment and a return to full health.”
The 23-year-old Lindblom had been sidelined for the past week with what the team had been calling an upper-body injury. He appeared in 30 games this season and was off to the best start of his career.
Ewing’s sarcoma is an extremely rare form of cancer (fewer than 1,000 cases per year) that is usually found in the bones of the legs, arms, chest, pelvis, spine, or skull. It typically impacts adolescents and young adults.